What is Alpelisib: Uses, Dosage, Side Effects and More

Alpelisib is a targeted cancer medication that helps treat certain types of advanced breast cancer. It's designed to work alongside hormone therapy to slow down cancer growth when other treatments haven't been effective enough.

This medication represents a more precise approach to cancer treatment. Instead of affecting all rapidly dividing cells like traditional chemotherapy, alpelisib targets specific proteins that fuel certain breast cancers.

What is Alpelisib?

Alpelisib is a prescription medication that belongs to a class of drugs called PI3K inhibitors. It blocks specific proteins that help cancer cells grow and multiply in your body.

The medication comes as oral tablets that you take by mouth. It's specifically designed for people with hormone receptor-positive, HER2-negative advanced breast cancer that has a particular genetic mutation called PIK3CA.

Your doctor will test your cancer cells to see if you have this specific mutation before prescribing alpelisib. This genetic testing helps ensure the medication will work effectively for your particular type of cancer.

What is Alpelisib Used For?

Alpelisib treats advanced or metastatic breast cancer that has specific characteristics. It's used when your cancer has grown despite previous hormone therapy treatments.

The medication is specifically approved for hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation. This means your cancer cells have receptors that respond to hormones like estrogen, but don't have too much of the HER2 protein.

You'll typically take alpelisib in combination with fulvestrant, another hormone therapy medication. This combination approach helps attack the cancer from multiple angles, potentially slowing its growth more effectively than either medication alone.

How Does Alpelisib Work?

Alpelisib works by blocking a specific pathway that cancer cells use to grow and survive. It targets an enzyme called PI3K that sends growth signals to cancer cells.

Think of PI3K as a key that unlocks the door for cancer cells to multiply. By blocking this enzyme, alpelisib essentially locks that door, making it harder for cancer cells to receive the signals they need to grow.

This medication is considered a moderately strong targeted therapy. While it's potent against cancer cells with the PIK3CA mutation, it's generally easier on your body than traditional chemotherapy because it's more selective in what it targets.

How Should I Take Alpelisib?

Take alpelisib exactly as your doctor prescribes, usually once daily at the same time each day. You can take it with or without food, but try to be consistent with your choice.

Swallow the tablets whole with a full glass of water. Don't crush, chew, or break the tablets, as this can affect how the medication works in your body.

If you eat before taking alpelisib, choose a light meal or snack. Heavy, high-fat meals might increase some side effects. Many people find taking it with a small amount of food helps reduce stomach upset.

Store your medication at room temperature, away from heat and moisture. Keep it in its original container and away from children and pets.

How Long Should I Take Alpelisib For?

You'll typically continue taking alpelisib for as long as it's helping control your cancer and you're tolerating it well. This could be months or even years, depending on your individual response.

Your doctor will monitor your progress through regular check-ups, blood tests, and imaging scans. These help determine if the medication is working effectively and if you're experiencing any concerning side effects.

The treatment duration varies greatly from person to person. Some people take it for several months, while others may continue for years. Your medical team will work with you to find the right balance between cancer control and quality of life.

What Are the Side Effects of Alpelisib?

Like all cancer medications, alpelisib can cause side effects, though not everyone experiences them. The most common ones are generally manageable with proper care and monitoring.

Here are the more common side effects you might experience:

• High blood sugar levels (hyperglycemia)
• Diarrhea
• Nausea and vomiting
• Fatigue and weakness
• Decreased appetite
• Mouth sores
• Skin rash
• Hair loss or thinning

Your healthcare team will monitor your blood sugar levels regularly, as this is the most significant side effect. They'll teach you how to manage this and may recommend dietary changes or medications if needed.

Some less common but more serious side effects can occur, though they're relatively rare:

• Severe skin reactions
• Lung inflammation (pneumonitis)
• Severe diarrhea leading to dehydration
• Kidney problems
• Severe allergic reactions

These serious side effects require immediate medical attention. Your doctor will discuss warning signs to watch for and when to contact them right away.

Who Should Not Take Alpelisib?

Alpelisib isn't suitable for everyone, and your doctor will carefully evaluate whether it's right for you. People with certain health conditions may need to avoid this medication or use it with extra caution.

You shouldn't take alpelisib if you're allergic to it or any of its ingredients. Your doctor will also be cautious if you have diabetes or pre-diabetes, as the medication can raise blood sugar levels.

People with certain other conditions need special consideration:

• Uncontrolled diabetes
• Severe kidney disease
• Active lung disease
• History of severe skin reactions to medications
• Pregnancy or breastfeeding

Your doctor will weigh the potential benefits against the risks for your specific situation. They may recommend additional monitoring or alternative treatments if alpelisib isn't suitable for you.

Alpelisib Brand Name

Alpelisib is sold under the brand name Piqray. This is the only brand name currently available for this medication in most countries.

You might see both names used interchangeably by your healthcare team. Whether they say "alpelisib" or "Piqray," they're referring to the same medication.

The medication is manufactured by Novartis and is available in most major healthcare systems worldwide. Your pharmacy will typically stock it under the Piqray brand name.

Alpelisib Alternatives

If alpelisib isn't suitable for you or stops working effectively, several alternative treatments exist for advanced breast cancer. Your doctor can discuss these options based on your specific situation.

Other targeted therapies that might be considered include:

• CDK4/6 inhibitors (like palbociclib, ribociclib, or abemaciclib)
• mTOR inhibitors (like everolimus)
• Other PI3K inhibitors in development
• Different hormone therapy combinations

The best alternative depends on your cancer's specific characteristics, previous treatments, and overall health. Your oncologist will consider factors like genetic mutations, hormone receptor status, and how well you've responded to other treatments.

Sometimes, participating in clinical trials offers access to newer treatments that aren't yet widely available. Your medical team can help you explore all appropriate options.

Is Alpelisib Better Than Other PI3K Inhibitors?

Alpelisib is currently the most studied and widely available PI3K inhibitor for breast cancer treatment. It's specifically designed to target the alpha form of PI3K, which is most commonly mutated in breast cancer.

Compared to other PI3K inhibitors that have been studied, alpelisib appears to have a more favorable side effect profile. It's generally better tolerated than some earlier medications in this class that caused more severe complications.

However, "better" depends on your individual circumstances. Some people may respond better to different medications, and your doctor will consider your specific cancer characteristics, health status, and treatment history when making recommendations.

The field of targeted cancer therapy is rapidly evolving, with new medications being developed regularly. Your oncologist stays current with the latest research to ensure you receive the most appropriate treatment.